| 01/15 | ASTRAZENECA : Deutsche Bank Initiates Coverage on AstraZeneca With Buy Rating | MT |
| 01/15 | ASTRAZENECA : Buy rating from Deutsche Bank | MD |
| 01/15 | ASTRAZENECA : Buy rating from Berenberg | MD |
| 01/14 | ASTRAZENECA : UBS reaffirms its Neutral rating | MD |
| 01/11 | ASTRAZENECA : SocGen Trims AstraZeneca PT, Maintains Buy Rating | MT |
| 2020 | ASTRAZENECA : AlphaValue Upgrades AstraZeneca to Add from Reduce | MT |
| 2020 | ASTRAZENECA : Receives a Sell rating from Goldman Sachs | MD |
| 2020 | ASTRAZENECA : Liberum Trims AstraZeneca PT, Maintains Buy Rating | MT |
| 2020 | ASTRAZENECA : Gets a Sell rating from DZ Bank | MD |
| 2020 | Oppenheimer Downgraded Alexion Pharmaceuticals to Not Rated From Perform Foll.. | MT |
| 2020 | ALEXION PHARMACEUTICALS : RBC Capital Adjusts Alexion Pharmaceuticals PT to $175.. | MT |
| 2020 | Credit Suisse Downgrades Alexion to Neutral from Outperform on Sale to AstraZ.. | MT |
| 2020 | ASTRAZENECA : Receives a Buy rating from Kepler Cheuvreux | MD |
| 2020 | ALEXION PHARMACEUTICALS : Wedbush Downgrades Alexion Pharmaceuticals to Neutral .. | MT |
| 2020 | ASTRAZENECA : UBS gives a Neutral rating | MD |
| 2020 | ASTRAZENECA : Credit Suisse reiterates its Buy rating | MD |
| 2020 | ASTRAZENECA : Jefferies reiterates its Neutral rating | MD |
| 2020 | ASTRAZENECA : Berenberg keeps its Buy rating | MD |
| 2020 | ASTRAZENECA : Receives a Sell rating from Goldman Sachs | MD |
| 2020 | Jefferies Affirms AstraZeneca at Hold, Lifts PT | MT |
| 2020 | ASTRAZENECA : UBS remains Neutral | MD |
| 2020 | Morgan Stanley Upgrades AstraZeneca to Overweight From Equal-Weight | MT |
| 2020 | ASTRAZENECA : Upgraded to Buy by Morgan Stanley | MD |
| 2020 | Sensex, Nifty end at record high on consumer goods boost | RE |
| 2020 | Morgan Stanley Upgrades AstraZeneca to Overweight from Equalweight, Boosts Ta.. | MT |
| 2020 | WALL STREET WEEK AHEAD : After blazing energy rally, investors check the fuel ga.. | RE |
| 2020 | ASTRAZENECA : JP Morgan keeps its Buy rating | MD |
| 2020 | Pfizer and BioNTech's Covid-19 Vaccine Wins U.K. Authorization -- 7th Update | DJ |
| 2020 | UK approves Pfizer-BioNTech COVID-19 vaccine in world first | RE |
| 2020 | UBS Upgrades AstraZeneca to Neutral From Sell | MT |
| 2020 | ASTRAZENECA : UBS drops its Sell rating | MD |
| 2020 | UBS Upgrades AstraZeneca to Neutral From Sell, Raises PT | MT |
| 2020 | ASTRAZENECA : Vaccine is no shot in the arm yet for emerging markets | RE |
| 2020 | AstraZeneca Gears Up to Vaccinate the World Against Covid-19 | DJ |
| 2020 | Morgan Stanley Maintains AstraZeneca at Equalweight, Lifts PT | MT |
| 2020 | AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials.. | DJ |
| 2020 | ASTRAZENECA : Buy rating from Barclays | MD |
| 2020 | ASTRAZENECA : Buy rating from JP Morgan | MD |
| 2020 | ASTRAZENECA : Goldman Sachs remains a Sell rating | MD |
| 2020 | ASTRAZENECA : vaccine fails to lift euro zone gvt bonds | RE |
| 2020 | ASTRAZENECA : Buy rating from Berenberg | MD |
| 2020 | ASTRAZENECA : UBS remains a Sell rating | MD |
| 2020 | Rand jumps despite ratings downgrade, EM stocks rally on vaccine hopes | RE |
| 2020 | European shares slip as jump in virus cases offsets vaccine hopes | RE |
| 2020 | ASTRAZENECA : Gets a Neutral rating from Jefferies | MD |
| 2020 | ASTRAZENECA : Berenberg reiterates its Buy rating | MD |
| 2020 | Pfizer Says Covid Vaccine Is 95% Effective in Final Data, Will Seek Authoriza.. | DJ |
| 2020 | Pfizer's Covid-19 Vaccine 95% Effective in Final Results, Company to Seek App.. | DJ |
| 2020 | HSBC Upgrades AstraZeneca to Hold From Reduce | MT |
| 2020 | HSBC Upgrades AstraZeneca to Hold from Reduce, Boosts PT | MT |
| 2020 | ASTRAZENECA : Goldman Sachs reaffirms its Sell rating | MD |
| 2020 | ASTRAZENECA : JP Morgan keeps its Buy rating | MD |
| 2020 | ASTRAZENECA : Jefferies reaffirms its Neutral rating | MD |
| 2020 | ASTRAZENECA : Goldman Sachs reaffirms its Sell rating | MD |
| 2020 | ASTRAZENECA : Buy rating from Credit Suisse | MD |
| 2020 | ASTRAZENECA : UBS gives a Sell rating | MD |
| 2020 | ASTRAZENECA : JP Morgan reiterates its Buy rating | MD |
| 2020 | AstraZeneca Expects Covid-19 Vaccine Trial Results This Year -- Update | DJ |
| 2020 | AstraZeneca Expects Covid-19 Vaccine Trial Results This Year -- Earnings Revi.. | DJ |
| 2020 | ASTRAZENECA : COVID vaccine deliveries on ice as AstraZeneca awaits trial data | RE |
| 2020 | ASTRAZENECA : Jefferies sticks Neutral | MD |
| 2020 | ASTRAZENECA : Goldman Sachs keeps a Sell rating | MD |
| 2020 | AstraZeneca Expects Covid-19 Vaccine Trial Results This Year | DJ |
| 2020 | ASTRAZENECA : 3Q Net Profit Surged; Backs 2020 Guidance | DJ |
| 2020 | ASTRAZENECA : COVID vaccine deliveries on ice as AstraZeneca awaits trial data | RE |
| 2020 | ASTRAZENECA : JP Morgan reiterates its Buy rating | MD |
| 2020 | ASTRAZENECA : UBS remains a Sell rating | MD |
| 2020 | Travel, energy stocks drag UK shares lower, weighed by coronavirus fears | RE |
| 2020 | ASTRAZENECA : Receives a Sell rating from Goldman Sachs | MD |
| 2020 | ASTRAZENECA : Jefferies remains Neutral | MD |
| 2020 | European shares tumble on J&J vaccine worries, banks slide | RE |
| 2020 | ASTRAZENECA : Gets a Buy rating from JP Morgan | MD |
| 2020 | ASTRAZENECA : Berenberg gives a Buy rating | MD |
| 2020 | ASTRAZENECA : JP Morgan reaffirms its Buy rating | MD |
| 2020 | ASTRAZENECA : JP Morgan reiterates its Buy rating | MD |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
